PDCD1 and neoplasm: Synergy between vitamin C and anti‐PD‐1 has also been demonstrated, showing enhanced anti‐tumour activity in patients with B cell lymphoma, suggesting the potential benefit of a vitamin C–γδ T‐cell agonist combination therapy.104